Literature DB >> 26046848

Gastrointestinal Fibroblasts Have Specialized, Diverse Transcriptional Phenotypes: A Comprehensive Gene Expression Analysis of Human Fibroblasts.

Youichi Higuchi1, Motohiro Kojima2, Genichiro Ishii2, Kazuhiko Aoyagi3, Hiroki Sasaki3, Atsushi Ochiai4.   

Abstract

BACKGROUND: Fibroblasts are the principal stromal cells that exist in whole organs and play vital roles in many biological processes. Although the functional diversity of fibroblasts has been estimated, a comprehensive analysis of fibroblasts from the whole body has not been performed and their transcriptional diversity has not been sufficiently explored. The aim of this study was to elucidate the transcriptional diversity of human fibroblasts within the whole body.
METHODS: Global gene expression analysis was performed on 63 human primary fibroblasts from 13 organs. Of these, 32 fibroblasts from gastrointestinal organs (gastrointestinal fibroblasts: GIFs) were obtained from a pair of 2 anatomical sites: the submucosal layer (submucosal fibroblasts: SMFs) and the subperitoneal layer (subperitoneal fibroblasts: SPFs). Using hierarchical clustering analysis, we elucidated identifiable subgroups of fibroblasts and analyzed the transcriptional character of each subgroup.
RESULTS: In unsupervised clustering, 2 major clusters that separate GIFs and non-GIFs were observed. Organ- and anatomical site-dependent clusters within GIFs were also observed. The signature genes that discriminated GIFs from non-GIFs, SMFs from SPFs, and the fibroblasts of one organ from another organ consisted of genes associated with transcriptional regulation, signaling ligands, and extracellular matrix remodeling.
CONCLUSIONS: GIFs are characteristic fibroblasts with specific gene expressions from transcriptional regulation, signaling ligands, and extracellular matrix remodeling related genes. In addition, the anatomical site- and organ-dependent diversity of GIFs was also discovered. These features of GIFs contribute to their specific physiological function and homeostatic maintenance, and create a functional diversity of the gastrointestinal tract.

Entities:  

Mesh:

Year:  2015        PMID: 26046848      PMCID: PMC4457624          DOI: 10.1371/journal.pone.0129241

Source DB:  PubMed          Journal:  PLoS One        ISSN: 1932-6203            Impact factor:   3.240


Introduction

Fibroblasts are cells with spindle-shaped morphology that reside in human connective tissue. They are the principal type of stromal cell and perform multiple physiological and pathological functions. In addition to their basic function of contributing to the maintenance of a structural framework and of tissue homeostasis with their ability to synthesize many extracellular matrix and growth factors, they also play an important role in fetal development, wound healing, and cancer progression [1, 2]. They are widely distributed within the body and play variable roles within organs with different functions. However, their lack of specific molecular markers and common morphological features hinder functional classification [3]. Despite this, in many organs, the topographical or anatomical diversity of fibroblasts has been investigated. In colonic tissue, subepithelial fibroblasts are known to contribute to the maintenance of epithelial cell homeostasis, wound healing, and immune responses [4, 5], and subperitoneal fibroblasts are known to produce peritoneal fluid and facilitate appropriate functioning of intra-abdominal organs [6, 7]. With that said, previous studies analyzing the diversity of fibroblasts have analyzed fibroblasts from only one or few organs, and comprehensive analyses examining the diversity of fibroblasts within the whole body are lacking. Recently, the global gene expressions of skin and colonic tissue fibroblasts have been reported, and their topological and anatomical diversities were elucidated [8-11]. Global gene expression analysis can be an effective and robust method to grasp the diversity of fibroblasts in an organ. Studies utilizing this method may determine site-specific markers of fibroblasts and generate basic data to understand the organ-specific microenvironments they create. In this study, we obtained 63 human primary fibroblasts from 13 organs from around the whole body, and global gene expression analyses were performed using Affymetrix GeneChip U133 Plus 2. The aim of this study was to elucidate the transcriptional diversity of fibroblasts across the whole body and to reveal gene expression patterns that discriminate their diversity. To this end, we identified gastrointestinal fibroblasts (GIFs) as a group within the body with a special gene expression. Then, we analyzed the gene expression pattern of GIFs intensively to elucidate their transcriptional character. Further diversity within GIFs was also analyzed, and the genes that contributed to form diversity within GIFs were identified.

Materials and Methods

Ethics Statement

This study was approved by the National Cancer Center Hospital East Institutional Reviews Board (No: 19–021). A written comprehensive prior consent arrangement to use any biologic materials for research was obtained from each donor, including use of tissue sections, RNA, DNA, protein, and cultured cells. In this study, human primary fibroblasts (submucosal fibroblasts, SMFs; subperitoneal fibroblasts, SPFs; Lung tissue fibroblasts, LuFs; vascular adventitial fibroblasts, VAFs; breast dermal fibroblasts, DeFs; mammary fibroblasts from Japanese subjects, J_MaFs; liver fibroblasts, LiFs; and gallbladder fibroblasts, GaFs), tissue total RNA samples, and tissue section samples were obtained with protocols approved by the institutional review board.

Isolation and primary culture of fibroblasts

Human primary fibroblasts were obtained from surgically resected normal tissues more than 5 cm away from the tumor. GIFs were obtained from the esophagus, pyloric antrum of the stomach, third portion of the duodenum, terminal ileum, and sigmoid colon. These tissues were separated into submucosal and subperitoneal tissue as described previously [11, 12]. Gastrointestinal tissue was dissected from the muscular layer on the luminal side, and the lamina propria and mucosal layer tissues were obtained. Next, the lamina propria was scrubbed away to obtain submucosal tissue. Subperitoneal tissue was obtained from the mesentery of gastrointestinal tissue by using operating tweezers and scissors (S1A Fig). After being washed with phosphate buffered saline (PBS) 3 times, each tissue was incubated in PBS with 0.05% trypsin (Sigma) for 4 hours at 37°C. After incubation, the remaining tissue was rejected, and the trypsin solution was centrifuged to obtain a pellet of fibroblast cells. Then cells were seeded into 6 cm dishes (BD Falcon) and cultured at 37°C and 5.0% CO2 condition. GaFs were obtained from the gallbladder wall using trypsin incubation. LuFs, VAFs, DeFs, J_MaFs, and LiFs were obtained by attaching the tissue sections to the plastic dish as described previously [13]. Tissues were washed with PBS, minced into small pieces with a diameter of approximately 5 mm, attached on a 6 cm dish with 1.0 mL of MF medium (Toyobo), and cultured at 37°C and 5.0% CO2 condition. After migrated spindle-shaped cells were observed, tissue pieces were removed to obtain fibroblasts. Purchased cell lines were 3 mammary fibroblasts from Caucasians (C_MaFs; Zenbio), 2 hepatic stellate cells (HSCs; Zenbio), 3 uterine fibroblasts (UtFs; LIFE LINE CELL TECHNOLOGY), and 3 prostate fibroblasts (PrFs; ScienCell). All fibroblasts were grown and maintained in MF medium and characterization using immunofluorescence staining and flow cytometry analysis was performed to check their culture purity (S1B and S1C Fig). All experiments were performed with cells within 8 passages. Patient information for each fibroblast, including the donor’s sex, age, and race, are described in S1 Table.

Immunofluorescence staining

For the immunofluorescence staining of fibroblasts, 2.0×103 fibroblasts were plated on a culture slide (BD Falcon) and cultured for 2 days. Cultured cells were fixed in cold methanol for 10 minutes and cold acetone for 5 minutes on ice. After fixation, cells were blocked in 2% NSS/PBS for 30 minutes. Cells were incubated with primary antibodies at room temperature for 1 hour. After PBS washing, cells were incubated with goat anti-mouse Alexa Flour 488 nm (Invitrogen), goat anti-rabbit Alexa Flour 488 nm (Invitrogen), or donkey anti-goat Alexa Flour 546 nm at room temperature for 1 hour, and then mounted with VectaShield Mounting Medium with DAPI (Vector Laboratories, Inc.) for counterstaining. For the confirmation of the expression of msh homeobox 1 (MSX1) in human gastrointestinal tissue, paraffin-embedded tissue was obtained from 3 surgically resected human normal colonic and gastric tissues. After deparaffinization of the tissue, antigen retrieval was performed with pH 9.0 Tris-EDTA buffer (Dako) at 95°C for 20 minutes, and the tissue was incubated with mouse-monoclonal anti-Vimentin (Dako) and rabbit-polyclonal anti-MSX1 (Sigma) at 4°C overnight followed by goat anti-mouse Alexa Flour 546 nm (Invitrogen) and goat anti-rabbit Alexa Flour 488 nm. Ten fields of submucosal and subserosal areas were captured and the nuclear protein expressions of MSX1 in vimentin-positive, spindle-shaped fibroblastic cells were evaluated by calculating the color difference [14]. The immunofluorescence images were captured on an Axio Imager M1 (Zeiss) with AxioCam HRc (Zeiss), and images were analyzed with Axio Vision 4.7.1 (Zeiss) and Photoshop CS5 (Adobe Systems). The primary antibodies used are described in S2 Table.

Flow cytometry analysis

Flow cytometry analysis was performed to characterize the cell surface antigen of the fibroblasts. FACSCalibur (Beckton-Dickinson, San Jose, CA) was used and a minimum of 10,000 events counted with Cell Quest software (Beckton-Dickinson Labware, Franklin Lakes, NF). Cells were trypsinized, centrifuged, and incubated with primary antibody for 15 minutes on ice in a dark condition. They were then washed with PBS containing 3% fetal bovine serum (FBS; Sigma) and 0.05% Na2N3, and then were incubated with rabbit anti-mouse IgG/FITC (Dako) as a secondary antibody for 15 minutes on ice in a dark condition. Washing with PBS again, a FACS scan was performed using Cell Quest software. The primary antibodies used are described in S2 Table.

Isolation and purification of total RNA

To obtain the total RNA from cultured fibroblasts, 5.0×105 fibroblasts were plated on a 10 cm dish (BD Falcon) and cultured in Dulbecco’s modified Eagle's medium (DMEM; Sigma) with 10% FBS and 1% penicillin streptomycin (Sigma) for 48 hours. Then, the medium was changed into DMEM without FBS and the cells were cultured for 48 hours. After culturing, the cells were washed with PBS and suspended in 1.0 mL of TRIzol reagent (Invitrogen) using Cell Scraper (SARSTEDT), and stored at -80°C. The total RNA was purified from thawed samples using TRIzol / RNeasy minicolumn protocol (QIAGEN). RNase-free DNase (QIAGEN) was treated on column for 15 minutes to remove the minimum genomic DNA contamination. A quality check of all total RNA samples was performed using Agilent Bioanalyzer with an RNA 6000 Nano Assay kit (Agilent Technology), and confirmed that the RNA integrity numbers of all RNA samples were > 9.0. To obtain the total RNA from human tissue, we homogenized the separated submucosal and subperitoneal tissues into TRIzol reagent using Tissue Lyser II (QIAGEN), and stored the solution at -80°C. Purification of total RNA was performed as described earlier.

Gene expression analysis using microarrays

We used GeneChip Human Genome U133 Plus 2 arrays (Affymetrix), containing 54,675 probe sets, to analyze the mRNA expression levels of approximately 47,000 transcripts and variants from 38,500 well-characterized human genes. Target complementary RNA was generated from 100 ng of total RNA from each sample using a 3’ IVT Express Kit (Affymetrix). The procedures for target hybridization, washing, and staining with signal amplification were conducted according to the supplier's protocols. The arrays were scanned with a GeneChip Scanner 3000 (Affymetrix). The primary expression microarray data are available at Gene Expression Omnibus (http://www.ncbi.nlm.nih.gov/geo/; NCBI). The accession number of 63 primary fibroblasts microarray data is GSE63626; of these, 3 pairs of colon SMFs and SPFs microarray data are previously reported in GSE53059.

Statistical analysis of microarrays

Gene expression data were analyzed with GeneSpring GX12.6 (Agilent Technologies). Raw data were summarized using microarray suite 5 (MAS5) algorithm and normalized into log transformed and median centered data to perform the numerical analysis to permit gene selection. For unsupervised hierarchical clustering, we used probe sets that were reliably measured and varied by 3-fold above the global median in at least 10% of samples. The differentially expressed probe sets used in supervised hierarchical clustering were selected based on P < 0.05 and fold change > 2.0. P values were calculated using unpaired t-test or one way ANOVA with Benjamini and Hochberg multiple correction. For hierarchical clustering, average linkage clustering with Pearson correlation distance was performed.

Validation of GIF signature genes in independent microarray data sets

To validate the distinct gene expression between GIFs and non-GIFs, we used the public microarray data of human primary fibroblasts analyzed using Affymetrix GeneChip U133A Plus 2 array. Three data sets of colon mucosal fibroblasts (GSE15322, GSE29316, GSE39394) and 1 data set of stomach fibroblasts (GSE44740) were used as GIF samples, and 2 data sets of mammary gland fibroblasts (GSE20086, GSE25619) and 2 data sets of lung fibroblasts (GSE23066, GSE44723) were used as non-GIF samples [15-PLoS One. 2013 ">22]. Hierarchical clustering based on 995 GIF signature genes were performed, and whether the first branch distinguishes the GIFs and non-GIFs or not were validated.

Quantitative real-time reverse transcriptase-polymerase chain reaction (qRT-PCR)

The cDNA was synthesized using the PrimScript RT reagent Kit (TaKaRa), according to the manufacturer’s protocol. The qRT-PCR was performed in a Light Cycler System (Roche) using SYBR Premix Ex Taq (Tli RNaseH Plus; TaKaRa) according to the manufacturer’s protocol. The target gene expression was normalized with the gene expression of GAPDH. The primer designs used in this study are described in S3 Table.

Statistical analysis

The significance of differences between any 2 groups was evaluated by using Student’s t-test. A difference was considered significant at P < 0.05. The significance of distribution of GIFs or non-GIFs, SMFs, and SPFs in Fig 1 were evaluated by the χ2 test. The error bars show the mean ± SEM.
Fig 1

Diversity of Gene Expression in Human Gastrointestinal Fibroblasts.

(A) Diversity of gene expression of 63 primary human fibroblasts. Each column is colored with the fibroblast origin; dermal fibroblasts (DeFs), mammary fibroblasts from Japanese (J_MaFs), mammary fibroblasts from Caucasians (C_MaFs) are colored brown; prostate fibroblasts (PrFs) and uterus fibroblasts (UtFs) are colored light blue; gallbladder fibroblasts (GaFs), hepatic stellate cells (HSCs), and liver fibroblasts (LiFs) are colored gray; lung fibroblasts (LuFs) are colored green; submucosal fibroblasts from the gastrointestinal tract (SMFs) are colored red; subperitoneal fibroblasts from the gastrointestinal tract (SPFs) are colored blue; and vascular adventitial fibroblasts (VAFs) are colored pink. The color scale of the gene expression range is +5 to -5 logs on log base 2. (B) Expansion view of the dendrogram seen in (A). The first bifurcation of the dendrogram separated gastrointestinal fibroblasts (GIFs) and non-GIFs significantly (P < 0.001). Furthermore, clustering depending on anatomical site and gastrointestinal organ was also observed.

Diversity of Gene Expression in Human Gastrointestinal Fibroblasts.

(A) Diversity of gene expression of 63 primary human fibroblasts. Each column is colored with the fibroblast origin; dermal fibroblasts (DeFs), mammary fibroblasts from Japanese (J_MaFs), mammary fibroblasts from Caucasians (C_MaFs) are colored brown; prostate fibroblasts (PrFs) and uterus fibroblasts (UtFs) are colored light blue; gallbladder fibroblasts (GaFs), hepatic stellate cells (HSCs), and liver fibroblasts (LiFs) are colored gray; lung fibroblasts (LuFs) are colored green; submucosal fibroblasts from the gastrointestinal tract (SMFs) are colored red; subperitoneal fibroblasts from the gastrointestinal tract (SPFs) are colored blue; and vascular adventitial fibroblasts (VAFs) are colored pink. The color scale of the gene expression range is +5 to -5 logs on log base 2. (B) Expansion view of the dendrogram seen in (A). The first bifurcation of the dendrogram separated gastrointestinal fibroblasts (GIFs) and non-GIFs significantly (P < 0.001). Furthermore, clustering depending on anatomical site and gastrointestinal organ was also observed.

Results

GIFs show a characteristic and diverse gene expression profile depending on their organ and anatomical site

To elucidate the transcriptional diversity of fibroblasts, 63 samples of human primary fibroblasts from the whole body, including 13 organs with anatomical variability, were cultured. All obtained cells were easily adhered to the plastic dish, grew well with at least 6 passages, and showed spindle-shaped morphology (S1A Fig). Immunofluorescence staining and flow cytometry analysis revealed that 11 of 13 obtained cells were positive for mesenchymal marker (vimentin, CD105), but negative for epithelial marker (cytokeratin AE1/3), smooth muscle marker (desmin), neural cells marker (GFAP), mesothelial marker (calretinin), endothelial marker (CD31), hematopoietic cells marker (CD34), lymphocyte marker (CD45), and monocyte marker (CD68; S1B and S1C Fig). We successfully confirmed almost all obtained cells were fibroblasts. Expectably, GaFs and LiFs were positive for desmin, which is the characteristic phenotype of stellate cells, like stromal cells in hepatic organs [23, 24]. The global gene expression profiles of the fibroblasts were analyzed using Affymetrix GeneChip U133 Plus 2. To characterize the transcriptional diversity of fibroblasts, 776 probe sets that were reliably measured and whose expression varied at least 3-fold from the median across all samples in at least 10% of samples were selected, and unsupervised hierarchical clustering analysis was performed. Overall, the first bifurcation of the dendrogram separated fibroblasts into 2 subgroups: GIFs enriched cluster (GEC) and non–GIFs enriched cluster (NGEC). Twenty-four of 32 GIFs were included in GEC, and 32 of 32 non-GIFs were in NGEC (P < 0.001, χ2 test). All of the 8 GIFs in NGEC were SPFs, whereas all SMFs were in GEC (P < 0.001). These results suggested the transcriptional specialty of GIFs. Organ-dependent clusters were also found both in GIFs and non-GIFs. However, fibroblasts were not clustered by the donor’s age or sex (Fig 1A and 1B, S1 Table). Further, HSCs (Zenbio) from Caucasians were located in the same cluster with LiFs (fibroblasts from liver) from Japanese donors, and C_MaFs (Zenbio) from Caucasians were located in the same cluster with J_MaFs and DeFs from Japanese donors (fibroblasts from mammary gland and breast dermal). Therefore, the transcriptional diversity of fibroblasts was not explained by the racial difference. Further, SMFs and SPFs in the colon, ileum, and stomach formed independent clusters, whereas those in duodenum and esophagus did not. These results indicated the existence of transcriptional diversity between SMFs and SPFs in some gastrointestinal organs.

The different transcriptional character between GIFs and non-GIFs

Next, we selected the significant different expressing probe sets between GIFs and non-GIFs, and a supervised hierarchical clustering analysis was performed. We selected 995 probe sets of GIF signature genes based on P < 0.05 (unpaired t-test) and fold change > 2.0 (Fig 2A and S4 Table). The GIF signature genes consisted of many genes related with transcriptional regulation (transcriptional factors and co-factors), signal ligands (growth factors, cytokine, chemokine and other hormonal factors), and extracellular matrix regeneration (collagen molecules, proteoglycans, matrix metalloproteinase: Fig 2B). In addition, the validation study of these signature genes was performed using 8 independent microarray data sets of human primary fibroblasts in public GEO datasets, including 3 sets of colon mucosal fibroblasts (GSE15322, GSE29316, GSE39394), 1 set of stomach mucosal fibroblasts (GSE44740), 2 sets of normal mammary gland fibroblasts (GSE20086, GSE25619), and 2 sets of lung fibroblasts (GSE23066, GSE44723; lung tissue and airway fibroblasts). By hierarchical cluster analysis using 995 GIF signature genes, we successfully determined that the first bifurcation of the dendrogram separated 11 GIF samples and 18 non-GIF samples into different clusters (S2A–S2C Fig). These results revealed that the differences between GIFs and non–GIFs were characterized by their expression of genes related to transcriptional regulation, signal ligands, and extracellular matrix remodeling.
Fig 2

The Transcriptional Differences between Gastrointestinal Fibroblasts and Non–Gastrointestinal Fibroblasts.

(A) Supervised clustering using the significant different expressed probe sets between gastrointestinal fibroblasts (GIFs) and non-GIFs. The 995 significant probe sets were selected based on P < 0.05 and fold change > 2.0 (one-way ANOVA). The red bars indicate a GIF sample, and blue bars indicate a non-GIF sample. The top significant genes are shown on the right. The color scale of gene expression is the same as Fig 1A. (B) Distinct expression of the genes related with transcriptional regulation, signal ligands, and extracellular matrix remodeling in GIFs and Non-GIFs.

The Transcriptional Differences between Gastrointestinal Fibroblasts and Non–Gastrointestinal Fibroblasts.

(A) Supervised clustering using the significant different expressed probe sets between gastrointestinal fibroblasts (GIFs) and non-GIFs. The 995 significant probe sets were selected based on P < 0.05 and fold change > 2.0 (one-way ANOVA). The red bars indicate a GIF sample, and blue bars indicate a non-GIF sample. The top significant genes are shown on the right. The color scale of gene expression is the same as Fig 1A. (B) Distinct expression of the genes related with transcriptional regulation, signal ligands, and extracellular matrix remodeling in GIFs and Non-GIFs.

Anatomical site dependent diversity in GIFs

To elucidate the transcriptional difference between different anatomical sites of SMFs and SPFs, unsupervised clustering was performed in each organ within the gastrointestinal tract. Although we found a transcriptional difference between SMFs and SPFs in the colon, ileum, and stomach, these differences were not found in the duodenum and esophagus (Fig 3A). Therefore, supervised analyses between SMFs and SPFs were performed for stomach, ileum, and colon fibroblasts, and 498 probe sets were identified as anatomical site signature genes in GIFs (Fig 3B and S5 Table). The anatomical site signature genes were also characterized with the genes related with transcriptional regulation, signal ligands, and extracellular matrix remodeling (Fig 3C).
Fig 3

Anatomical Site Dependent Diversity in Gastrointestinal Fibroblasts.

(A) Unsupervised clustering in the colon, ileum, stomach, duodenum, and esophagus derived fibroblasts samples. Submucosal fibroblasts (SMFs) and subperitoneal fibroblasts (SPFs) from the colon, ileum, and stomach showed different gene expression profiles, whereas those from the duodenum and esophagus were not separated into different clusters. The red bar indicates SMFs samples and the blue bar indicates SPFs samples. The color scale of gene expression is same as Fig 1A. (B) Supervised clustering between SMFs and SPFs samples in the colon, ileum, and stomach. A total of 498 probe sets were selected based on P < 0.05 and fold change > 2.0 (t-test unpaired). The top significant genes are shown on the right. (C) Distinct expression of the genes related with transcriptional regulation, signal ligands, and extracellular matrix remodeling in SMFs and SPFs.

Anatomical Site Dependent Diversity in Gastrointestinal Fibroblasts.

(A) Unsupervised clustering in the colon, ileum, stomach, duodenum, and esophagus derived fibroblasts samples. Submucosal fibroblasts (SMFs) and subperitoneal fibroblasts (SPFs) from the colon, ileum, and stomach showed different gene expression profiles, whereas those from the duodenum and esophagus were not separated into different clusters. The red bar indicates SMFs samples and the blue bar indicates SPFs samples. The color scale of gene expression is same as Fig 1A. (B) Supervised clustering between SMFs and SPFs samples in the colon, ileum, and stomach. A total of 498 probe sets were selected based on P < 0.05 and fold change > 2.0 (t-test unpaired). The top significant genes are shown on the right. (C) Distinct expression of the genes related with transcriptional regulation, signal ligands, and extracellular matrix remodeling in SMFs and SPFs.

Organ dependent diversity in GIFs

Next, we investigated the organ-dependent diversity in GIFs. Because the diversity of GIFs was also influenced by their anatomical site, unsupervised analysis was performed in SMFs and SPFs separately. Unsupervised analysis revealed that both SMFs and SPFs had an organ-dependent diversity (Fig 4A). Next, based on P < 0.05 (one way ANOVA) and fold change > 2.0, the organ-specific genes in SMFs and SPFs were selected respectively. Then using a Venn diagram of organ specific genes in SMFs and SPFs, we identified 87 probe sets of common organ signature genes (Fig 4B and S6 Table). Hierarchical clustering based on these 87 probe sets successfully drew the dendrogram that separated GIF samples into their organs, but not into their anatomical sites (Fig 4C). Because many homeotic genes were observed in common organ signature genes (15 of 87 probe sets), unsupervised clustering based on 35 probe sets of homeotic genes that were relatively expressed in GIFs was performed. Interestingly, these homeotic genes tended to separate GIF samples into their organs, and showed regional expression patterns depending on the anterior-posterior axis of gastrointestinal tract. (Fig 4D and S3 Fig).
Fig 4

Organ Dependent Diversity in Gastrointestinal Fibroblasts.

(A) Unsupervised clustering within submucosal fibroblasts (SMFs) or subperitoneal fibroblasts (SPFs) samples. In both analyses, samples tended to be separated with their organs. The bar indicates each gastrointestinal organ: esophagus (brown), stomach (green), duodenum (light blue), ileum (gray), and colon (orange). (B) Organ signature genes in SMFs and SPFs. The probe sets that express specifically in each organ were selected based on P < 0.05, fold change > 2.0. The 433 probe sets were selected as SMFs organ signature genes, and 526 probe sets were selected as SPFs organ signature genes; of these, 87 probe sets expressed both SMFs and SPFs, defined as common organ signature genes. (C) Hierarchical clustering based on 87 common organ signature genes. The samples were clustered with their organs, but not with their anatomical site. (D) A schematic image of the expression pattern of homeotic genes in GIFs. The regional expression of homeotic genes depending on the anterior-posterior axis of the gastrointestinal tract was observed.

Organ Dependent Diversity in Gastrointestinal Fibroblasts.

(A) Unsupervised clustering within submucosal fibroblasts (SMFs) or subperitoneal fibroblasts (SPFs) samples. In both analyses, samples tended to be separated with their organs. The bar indicates each gastrointestinal organ: esophagus (brown), stomach (green), duodenum (light blue), ileum (gray), and colon (orange). (B) Organ signature genes in SMFs and SPFs. The probe sets that express specifically in each organ were selected based on P < 0.05, fold change > 2.0. The 433 probe sets were selected as SMFs organ signature genes, and 526 probe sets were selected as SPFs organ signature genes; of these, 87 probe sets expressed both SMFs and SPFs, defined as common organ signature genes. (C) Hierarchical clustering based on 87 common organ signature genes. The samples were clustered with their organs, but not with their anatomical site. (D) A schematic image of the expression pattern of homeotic genes in GIFs. The regional expression of homeotic genes depending on the anterior-posterior axis of the gastrointestinal tract was observed.

Anatomical site signature genes and common organ signature genes discriminate the topological diversity of GIFs

We found that the diversity of stomach, ileum, and colon fibroblasts is explained by the anatomical site signature genes and common organ signature genes. To test the distinction ability of these signature genes, we united 87 probe sets of common organ signature genes and 498 probe sets of anatomical site signature genes, and performed hierarchical clustering. As a result, the dendrogram showed the cluster that separated the samples depended on both their anatomical site and organ (Fig 5A). Using qRT-PCR and immunofluorescence staining, we confirmed the mRNA and protein expression of the signature genes, paired-like homeodomain 1 (PITX1) in SMFs, MSX1 in SPFs, homeobox A10 (HOXA10) in colon fibroblasts, and homeobox B8 (HOXB8) in stomach fibroblasts in independent samples (Fig 5B–5E, S4 Fig and S5 Fig). These results indicate that the transcriptional diversity within GIFs was mainly discriminated by their 2 topological axes, which are anatomical site and gastrointestinal organ.
Fig 5

Anatomical Site and Organ Signature Genes Discriminate the Topological Diversity of Gastrointestinal Fibroblasts.

(A) Hierarchical clustering of the stomach, ileum, and colon fibroblasts, based on 585 probe sets that consisted of 498 anatomical site signature genes and 87 common organ signature genes, as shown in Figs 3 and 4. The bar indicates the positional information of the samples: upper bar indicates submucosal fibroblasts (red) or subperitoneal fibroblasts (blue), and the lower bar indicates stomach (gray), ileum (green), or colon (orange). (B-E) The validation study of the anatomical site and organ signature genes in independent fibroblasts samples. The mRNA expression of SPFs signature: MSX1 (B), SMFs signature: PITX1 (C), colon fibroblasts signature: HOXA10 (D), and stomach fibroblasts signature: HOXB8 (E) were calculated (n = 3).

Anatomical Site and Organ Signature Genes Discriminate the Topological Diversity of Gastrointestinal Fibroblasts.

(A) Hierarchical clustering of the stomach, ileum, and colon fibroblasts, based on 585 probe sets that consisted of 498 anatomical site signature genes and 87 common organ signature genes, as shown in Figs 3 and 4. The bar indicates the positional information of the samples: upper bar indicates submucosal fibroblasts (red) or subperitoneal fibroblasts (blue), and the lower bar indicates stomach (gray), ileum (green), or colon (orange). (B-E) The validation study of the anatomical site and organ signature genes in independent fibroblasts samples. The mRNA expression of SPFs signature: MSX1 (B), SMFs signature: PITX1 (C), colon fibroblasts signature: HOXA10 (D), and stomach fibroblasts signature: HOXB8 (E) were calculated (n = 3).

Expression of anatomical site signature genes and organ signature genes in human gastrointestinal tissue

Finally, we confirmed the expression of anatomical site and organ signature genes in human colonic and gastric mesenchymal tissue. Using qRT-PCR, we confirmed that the gene expression of MSX1, HOXA10, and HOXB8 in human mesenchymal tissue was correlated with their expression in vitro, whereas we failed to confirm the gene expression of PITX1 (Fig 6A–6D). Furthermore, using immunofluorescence staining, we observed the protein expression of SPFs signature gene MSX1 in human tissue. We calculated the nuclear protein expression of MSX1 in vimentin-positive, spindle-shaped fibroblastic cells, and confirmed that SPFs showed higher expression of MSX1 than SMFs in vivo (Fig 6E and 6F, S6 Fig).
Fig 6

The Expression of Anatomical Site and Organ Signature Genes in Human Tissue.

(A-D) The mRNA expression of anatomical and organ signature genes in human mesenchymal tissue (n = 3). SPFs signature: MSX1 (A), SMFs signature: PITX1 (B), colon fibroblasts signature: HOXA10 (C), stomach fibroblasts signature: HOXB8 (D). (E) Immunofluorescence staining of MSX1 in human colonic tissue. Arrow heads show vimentin-positive, spindle-shaped fibroblastic cells. (F) Semi-quantitative value of nuclear MSX1 expression in human colonic and gastric tissue (n = 3).

The Expression of Anatomical Site and Organ Signature Genes in Human Tissue.

(A-D) The mRNA expression of anatomical and organ signature genes in human mesenchymal tissue (n = 3). SPFs signature: MSX1 (A), SMFs signature: PITX1 (B), colon fibroblasts signature: HOXA10 (C), stomach fibroblasts signature: HOXB8 (D). (E) Immunofluorescence staining of MSX1 in human colonic tissue. Arrow heads show vimentin-positive, spindle-shaped fibroblastic cells. (F) Semi-quantitative value of nuclear MSX1 expression in human colonic and gastric tissue (n = 3).

Discussion

In this study, using fibroblasts from various organs, we demonstrated a detailed gene expression pattern of fibroblasts within the whole body. We firstly elucidated the origin-dependent transcriptional diversity of fibroblasts from the whole body, and found a distinct gene expression pattern in GIFs. Furthermore, we found anatomical site and organ dependent diversity in GIFs. The anatomical site and organ dependent diversity within GIFs were explained by the expression of the genes related with transcriptional regulation, signal ligands, and extracellular matrix remodeling. Our data of transcriptome analysis of human fibroblasts is the widest systematic study to provide direct evidence indicating specialized, diverse transcriptional phenotypes of GIFs. One of the vital roles of fibroblasts is secreting extracellular matrix to provide a structural framework and maintain homeostasis in tissue [25]. In this study, we observed the distinct gene expression of some collagen molecules, microfibrils, glycoproteins, proteoglycans, and matrix metalloproteinase in fibroblasts with various origins. Owing to various, site-specific expressions of these extracellular matrix genes, GIFs may create a tissue-specific mechanical microenvironment to support the physical function of gastrointestinal organs. Another vital role of fibroblasts is to regionalize the other cell types, such as epithelial cells, into tissue-specific phenotypes via embryonic development through reciprocal epithelial and mesenchymal interaction. Although epithelial cells are the major cell type that contributes to organ-specific physiological function in the gastrointestinal tract, their regionalization depending on the anterior-posterior axis is organized by mesenchymal cells [26-29]. Our data on GIFs with distinct transcriptional factors that relate to the developmental process validate that expression can be associated with epithelial regionalization and consequently allow GIFs to play distinct and variable physiological functions within gastrointestinal organs [30-32]. These site-specific gene expressions in fibroblasts seemed to be involved not only in the developmental process, but also in the tissue-specific differentiation of other cell types, including epithelial cells or mast cells [33-35]. Therefore, the elucidated organ-dependent diversity of GIFs may also be involved in the tissue-specific differentiation of adult stem cells in the gastrointestinal tract. Site-specific expression of humoral signal ligands, which include growth factors, cytokine and chemokine, and some Wnt, BMP, or TGF-beta signaling ligands, were also elucidated. In gastrointestinal tissue, such signal ligands contribute to homeostasis maintenance by supporting epithelial cell and smooth muscle cell proliferation and by attracting immune cells [36]. Many previous reports suggest that GIFs secrete various kinds of humoral factors and can create a cocktail to support tissue homeostasis [37-39]. Submucosal compartment of gastrointestinal tract exist between two distinct smooth muscle layers of the muscularis mucosae and muscularis propria. And the characteristic humoral factor expression of SMFs may contribute to the homeostasis of these smooth muscle tissues. Further, in specific conditions, such as a wound repairing process, some recent studies suggest that mesenchymal cells in the peritoneal area migrate to the wounded area of the epithelium, and contribute to the proliferation and structural morphogenesis of intestinal epithelium via non-canonical Wnt signaling [40-42]. Taken together with our observation of distinct expressions of humoral signaling factors, fibroblasts in each anatomical site may perform independent physiological functions, and potentially contribute to tissue homeostasis by distinct signaling pathways. Although all SMFs showed typical GIF transcriptional phenotypes, 8 of 16 SPFs showed non-GIF like transcriptional phenotypes. The human peritoneum is comprised of 2 anatomically distinct areas: the visceral and the parietal peritoneum. Whereas gastrointestinal organs are largely invested by the visceral peritoneum, some other organs, including the esophageal adventitia or duodenum peritoneum, are invested by parietal peritoneum. Furthermore, peritoneal tissue is histologically variable. For example, gastric peritoneum shows a fat-less thin histologic appearance, whereas colonic peritoneum shows a thick histologic appearance with abundant fat tissue. Such anatomical and histological heterogeneity of peritoneum tissue may contribute to the transcriptional diversity of SPFs. Next, interestingly, SPFs with non-GIF like phenotype showed transcriptional similarity with vascular adventitial fibroblasts (VAFs). Anatomically, vascular adventitia and serosa have continuity in the lung, and vascular adventitia and serosal tissue are known to contain a prominent elastic fiber component [43]. Previously, we reported both VAFs and SPFs possess robust tumor progression ability, and our results suggest the existence of a fibroblastic subgroup with special pathological function. Therefore, our data can potentially provide not only basic data about physiological function, but also important clues to estimate pathological processes of fibroblasts. In conclusion, GIFs are a distinct subgroup within the whole body, and were subclassified depending on their anatomical site or organ. These heterogeneous transcriptional phenotypes were mainly discriminated by the expression pattern of the genes related to transcriptional regulation, humoral signaling ligands, and extracellular matrix remodeling. The site-specific phenotypes of fibroblasts are related to embryogenesis, and may contribute to create the organ- or site-specific microenvironment necessary to maintain tissue homeostasis. These new data further demonstrate the wide spectrum of physiological and pathological roles these cells can play, and can be an important resource for future organogenetic studies.

Isolation and Characterization of Human Primary Fibroblasts.

(A) Schema of isolating human submucosal and subperitoneal fibroblasts. Human gastrointestinal tissue was separated into submucosal tissue and subperitoneal tissue, and fibroblasts were isolated from each tissue in pairs. (B) Characterization of human primary fibroblasts with immunofluorescence staining. Vimentin: mesenchymal marker; Cytokeratin: epithelial marker; Desmin: smooth muscle marker; GFAP: neural cells marker. (C) Characterization of cell surface antigens of human primary fibroblasts. CD31: endothelial marker; CD34: hematopoietic marker; CD45: lymphocyte marker; CD68: monocyte marker; CD105: mesenchymal marker. (TIF) Click here for additional data file.

Validation study of 995 Gastrointestinal Fibroblast Signature Genes in Public GEO Datasets.

(Related to (A) Hierarchical clustering of public human primary fibroblasts microarray data sets using 995 GIFs signature genes. An orange bar indicates colon fibroblasts samples (GIFs), a gray bar indicates stomach fibroblasts samples (GIFs), a brown bar indicates mammary gland fibroblasts samples (non-GIFs), and a green bar indicates lung fibroblasts samples (non-GIFs). The first branch of the dendrogram separated samples into GIF samples and non-GIF samples. (B, C) The expression of the GIF signature gene in validation data. GIF specific gene: PITX1 (B) and non-GIFs specific gene: TBX5 (C) are shown. (D, E) The expression of organ signature genes of GIFs in validation data. Colon fibroblasts specific gene: HOXA13 (D) and stomach fibroblasts specific gene: BARX1 (E) are shown. (TIF) Click here for additional data file.

Diverse Expression of Homeotic Genes in Gastrointestinal Fibroblasts.

(Related to Unsupervised hierarchical clustering of GIFs based on 35 probe sets of homeotic genes that were relatively expressed. The bar indicates each gastrointestinal organ: esophagus (brown), stomach (green), duodenum (blue), ileum (gray), and colon (red). (TIF) Click here for additional data file.

Protein expression of Anatomical Site Signature Genes in Gastrointestinal Fibroblasts.

(Related with (A) Immunofluorescence imaging of SPFs signature gene: MSX1 in colon SMFs and SPFs. Arrow heads indicating the fibroblasts with nuclear staining of MSX1. (B) Quantification of the ratio of MSX1 positive cells in colon and stomach SMFs and SPFs (n = 3). (C) Immunofluorescence imaging of SMFs signature gene: PITX1 in colon SMFs and SPFs. (D) Quantification of the ratio of PITX1 positive cells in colon and stomach SMFs and SPFs (n = 3). (TIF) Click here for additional data file.

Protein expression of Organ Signature Genes in Gastrointestinal Fibroblasts.

(Related with (A) Immunofluorescence imaging of colon fibroblasts signature gene: HOXA10 in colon and stomach SMFs. Arrow heads indicating the fibroblasts with nuclear staining of HOXA10. (B) Quantification of the ratio of HOXA10 positive cells in colon and stomach SMFs and SPFs (n = 3). (C) Immunofluorescence imaging of stomach fibroblasts signature gene: HOXB8 in colon and stomach SMFs. (D) Quantification of the ratio of HOXB8 positive cells in colon and stomach SMFs and SPFs (n = 3). (TIF) Click here for additional data file.

Determination of the Exposure Times to Semi-Quantitate the Nuclear Expression of MSX1 in Human Gastrointestinal Tissue.

(Related to (A) Immunofluorescence image of MSX1 in colon subperitoneal tissue for each exposure time. The fluorescence image of MSX1 shows clear and bright at an exposure time of 8.0 ms, without any background staining. Arrow heads indicate the vimentin-positive, spindle-shaped fibroblastic cells in the picture. (B) Immunofluorescence image of MSX1 in colon submucosal tissue for each exposure time. A weak fluorescence image can be observed at exposure time 8.0 ms. Arrow heads indicate the vimentin-positive, spindle-shaped fibroblastic cells in the picture. (C) Semi-quantitation of the nuclear expression of MSX1 in human gastrointestinal tissue fibroblasts. Nuclear color difference of the vimentin-positive, spindle-shaped fibroblastic cells in each picture were measured. The error bars show the mean ± SD of 4 fibroblastic cells in the picture. (TIF) Click here for additional data file.

Specimen information of the primary fibroblasts used for microarray analysis.

(XLSX) Click here for additional data file.

Primary antibodies used in this study.

(XLSX) Click here for additional data file.

Primer sequences used for qRT-PCR analysis.

(XLSX) Click here for additional data file.

List of 995 probe sets of gastrointestinal fibroblast signature genes.

(XLSX) Click here for additional data file.

List of 498 probe sets of anatomical site signature genes.

(XLSX) Click here for additional data file.

List of 87 probe sets of common organ signature genes.

(XLSX) Click here for additional data file.
  42 in total

Review 1.  The molecular basis of lung morphogenesis.

Authors:  D Warburton; M Schwarz; D Tefft; G Flores-Delgado; K D Anderson; W V Cardoso
Journal:  Mech Dev       Date:  2000-03-15       Impact factor: 1.882

2.  Redundant sources of Wnt regulate intestinal stem cells and promote formation of Paneth cells.

Authors:  Henner F Farin; Johan H Van Es; Hans Clevers
Journal:  Gastroenterology       Date:  2012-08-23       Impact factor: 22.682

3.  The enzyme Cyp26b1 mediates inhibition of mast cell activation by fibroblasts to maintain skin-barrier homeostasis.

Authors:  Yosuke Kurashima; Takeaki Amiya; Kumiko Fujisawa; Naoko Shibata; Yuji Suzuki; Yuta Kogure; Eri Hashimoto; Atsushi Otsuka; Kenji Kabashima; Shintaro Sato; Takeshi Sato; Masato Kubo; Shizuo Akira; Kensuke Miyake; Jun Kunisawa; Hiroshi Kiyono
Journal:  Immunity       Date:  2014-04-10       Impact factor: 31.745

4.  Stroma provides an intestinal stem cell niche in the absence of epithelial Wnts.

Authors:  Zahra Kabiri; Gediminas Greicius; Babita Madan; Steffen Biechele; Zhendong Zhong; Hamed Zaribafzadeh; Jamal Aliyev; Yonghui Wu; Ralph Bunte; Bart O Williams; Janet Rossant; David M Virshup
Journal:  Development       Date:  2014-06       Impact factor: 6.868

Review 5.  Stem cells and lineages of the intestine: a developmental and evolutionary perspective.

Authors:  Shigeo Takashima; David Gold; Volker Hartenstein
Journal:  Dev Genes Evol       Date:  2012-11-21       Impact factor: 0.900

6.  TLR4 activation enhances the PD-L1-mediated tolerogenic capacity of colonic CD90+ stromal cells.

Authors:  Ellen J Beswick; Jameel R Johnson; Jamal I Saada; Martin Humen; Jenifer House; Sara Dann; Suimin Qiu; Allan R Brasier; Don W Powell; Victor E Reyes; Irina V Pinchuk
Journal:  J Immunol       Date:  2014-07-28       Impact factor: 5.422

7.  The neuroendocrine phenotype of gastric myofibroblasts and its loss with cancer progression.

Authors:  Silvia Balabanova; Chris Holmberg; Islay Steele; Bahram Ebrahimi; Lucille Rainbow; Ted Burdyga; Cathy McCaig; Lazso Tiszlavicz; Nantaporn Lertkowit; Olivier T Giger; Simon Oliver; Ian Prior; Rod Dimaline; Deborah Simpson; Rob Beynon; Peter Hegyi; Timothy C Wang; Graham J Dockray; Andrea Varro
Journal:  Carcinogenesis       Date:  2014-04-07       Impact factor: 4.944

8.  Inflammatory cytokines promote growth of intestinal smooth muscle cells by induced expression of PDGF-Rβ.

Authors:  Dileep G Nair; Kurtis G Miller; Sandra R Lourenssen; Michael G Blennerhassett
Journal:  J Cell Mol Med       Date:  2014-01-13       Impact factor: 5.310

9.  Human subperitoneal fibroblast and cancer cell interaction creates microenvironment that enhances tumor progression and metastasis.

Authors:  Motohiro Kojima; Youichi Higuchi; Mitsuru Yokota; Genichiro Ishii; Norio Saito; Kazuhiko Aoyagi; Hiroki Sasaki; Atsushi Ochiai
Journal:  PLoS One       Date:  2014-02-04       Impact factor: 3.240

10.  Bleomycin induces molecular changes directly relevant to idiopathic pulmonary fibrosis: a model for "active" disease.

Authors:  Ruoqi Peng; Sriram Sridhar; Gaurav Tyagi; Jonathan E Phillips; Rosario Garrido; Paul Harris; Lisa Burns; Lorena Renteria; John Woods; Leena Chen; John Allard; Palanikumar Ravindran; Hans Bitter; Zhenmin Liang; Cory M Hogaboam; Chris Kitson; David C Budd; Jay S Fine; Carla M T Bauer; Christopher S Stevenson
Journal:  PLoS One       Date:  2013-04-02       Impact factor: 3.240

View more
  18 in total

1.  Characterization of a bovine intestinal myofibroblast cell line and stimulation using phytoglycogen-based nanoparticles bound to inosine monophosphate.

Authors:  K Jenik; T N Alkie; E Moore; J D Dejong; L E J Lee; S J DeWitte-Orr
Journal:  In Vitro Cell Dev Biol Anim       Date:  2021-01-20       Impact factor: 2.416

Review 2.  Host tissue determinants of tumour immunity.

Authors:  Hélène Salmon; Romain Remark; Sacha Gnjatic; Miriam Merad
Journal:  Nat Rev Cancer       Date:  2019-04       Impact factor: 60.716

Review 3.  Immunological Regulation of Intestinal Fibrosis in Inflammatory Bowel Disease.

Authors:  Giorgos Bamias; Theresa T Pizarro; Fabio Cominelli
Journal:  Inflamm Bowel Dis       Date:  2022-03-02       Impact factor: 7.290

4.  Distinct miRNA profiles in normal and gastric cancer myofibroblasts and significance in Wnt signaling.

Authors:  Liyi Wang; Islay Steele; Jothi Dinesh Kumar; Rod Dimaline; Puthen V Jithesh; Laszlo Tiszlavicz; Zita Reisz; Graham J Dockray; Andrea Varro
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2016-03-03       Impact factor: 4.052

5.  Myofibroblasts are distinguished from activated skin fibroblasts by the expression of AOC3 and other associated markers.

Authors:  Lin-Ting Hsia; Neil Ashley; Djamila Ouaret; Lai Mun Wang; Jennifer Wilding; Walter F Bodmer
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-28       Impact factor: 11.205

6.  Tumor-associated fibroblasts predominantly come from local and not circulating precursors.

Authors:  Ainhoa Arina; Christian Idel; Elizabeth M Hyjek; Maria-Luisa Alegre; Ying Wang; Vytautas P Bindokas; Ralph R Weichselbaum; Hans Schreiber
Journal:  Proc Natl Acad Sci U S A       Date:  2016-06-17       Impact factor: 11.205

Review 7.  Intestinal Fibrosis and Liver Fibrosis: Consequences of Chronic Inflammation or Independent Pathophysiology?

Authors:  Florian Rieder; Dominik Bettenworth; Jin Imai; Yutaka Inagaki
Journal:  Inflamm Intest Dis       Date:  2016-03-19

Review 8.  Location, location, location: how the tissue microenvironment affects inflammation in RA.

Authors:  Christopher D Buckley; Caroline Ospelt; Steffen Gay; Kim S Midwood
Journal:  Nat Rev Rheumatol       Date:  2021-02-01       Impact factor: 20.543

9.  Differentiation of Human Pluripotent Stem Cells into Colonic Organoids via Transient Activation of BMP Signaling.

Authors:  Jorge O Múnera; Nambirajan Sundaram; Scott A Rankin; David Hill; Carey Watson; Maxime Mahe; Jefferson E Vallance; Noah F Shroyer; Katie L Sinagoga; Adrian Zarzoso-Lacoste; Jonathan R Hudson; Jonathan C Howell; Praneet Chatuvedi; Jason R Spence; John M Shannon; Aaron M Zorn; Michael A Helmrath; James M Wells
Journal:  Cell Stem Cell       Date:  2017-06-22       Impact factor: 25.269

Review 10.  Special cancer microenvironment in human colonic cancer: Concept of cancer microenvironment formed by peritoneal invasion (CMPI) and implication of subperitoneal fibroblast in cancer progression.

Authors:  Motohiro Kojima; Atsushi Ochiai
Journal:  Pathol Int       Date:  2016-01-27       Impact factor: 2.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.